These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease. Olsson AG; Pedersen T; Bergdahl B Curr Opin Lipidol; 1995 Dec; 6(6):369-73. PubMed ID: 8750250 [TBL] [Abstract][Full Text] [Related]
35. Response of cases with acute myocardial infarction to infusion with low-molecular weight dextran (lomodex). Lal HB; Caroli RK; Malik RN; Sengupta D; Basumalik SN; Warrik HP; Behl AN Indian J Med Sci; 1968 Apr; 22(4):214-9. PubMed ID: 4875866 [No Abstract] [Full Text] [Related]
36. Cholesterol-lowering drugs for primary prevention? The WOSCOP Study. Muntoni S Pharmacol Res; 1997 Mar; 35(3):169-70. PubMed ID: 9229402 [No Abstract] [Full Text] [Related]
37. Lipid lowering does not improve endothelial function in subjects with poorly controlled diabetes. Mansourati J; Newman LG; Roman SH; Travis A; Rafey M; Phillips RA Diabetes Care; 2001 Dec; 24(12):2152-3. PubMed ID: 11723099 [No Abstract] [Full Text] [Related]
38. [Criteria necessary for evaluating the action of hypocholesterolemic drugs in man]. Beaumont V; Beaumont JL Bull Inst Natl Sante Rech Med; 1966; 21(3):425-34. PubMed ID: 5328825 [No Abstract] [Full Text] [Related]
39. The South African Lipid Guidelines: is there a need for an update? Raal FJ; Schamroth C; Klug E; Mills P Cardiovasc J S Afr; 2004; 15(2):53-4. PubMed ID: 15148537 [No Abstract] [Full Text] [Related]
40. Updated guidelines support even lower cholesterol levels for at-risk patients. Levenson D Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]